In vitro and in vivo characterization of four fibroblast tropomyosins produced in bacteria: TM-2, TM-3, TM-5a, and TM-5b are co-localized in interphase fibroblasts by unknown
In Vitro and In Vivo Characterization of Four Fibroblast 
Tropomyosins Produced in Bacteria: TM-2, TM-3, TM-Sa, 
and TM-Sb are Co-localized in Interphase Fibroblasts 
Mark E  Pittenger and David M. Helfman 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 
Abstract.  Most cell types express several tropomyosin 
isoforms, the individual functions of which are poorly 
understood.  In rat fibroblasts there are at least six 
isoforms; TM-1,  TM-2,  TM-3, TM-4,  TM-5a,  and 
TM-5b. TM-1 is the product of the/5 gene. TM-4 is pro- 
duced from the TM-4 gene, and TMs 2, 3,  5a, and 
5b are the products of the oe gene.  To begin to study 
the localization and function of the isoforms in fibro- 
blasts, cDNAs for TM isoforms 2,  3, 5a, and 5b were 
placed into bacterial expression vectors and used to 
produce TM isoforms. The bacterially produced TMs 
were determined to be full length by sequencing the 
amino- and carboxy termini.  These TMs were found 
to bind to F-actin in vitro, with properties similar to 
that of skeletal muscle TM.  In addition,  competition 
experiments demonstrated that TM-5b was better 
than TM-5a in displacing other TM isoforms from 
F-actin in vitro. To investigate the intracellular local- 
ization of these fibroblast isoforms, each was deriva- 
tized with a fluorescent chromophore and microinjected 
into rat fibroblasts. TM-2,  TM-3,  TM-5a,  and TM-5b 
were each found to associate along actin filaments. 
There was no preferred cellular location or subset of 
actin filaments for these isoforms. Furthermore,  co- 
injection of two isoforms labeled with different fluoro- 
chromes showed identical staining.  At the level of the 
light microscope, these isoforms from the ct gene do 
not appear to achieve different functions by binding to 
particular subsets of actin filaments or locations in 
cells.  Some alternative possibilities are discussed. The 
results show that bacterially produced TMs can be used 
to study in vitro and in vivo properties of the isoforms. 
T 
H~ tropomyosins (TMs) 1 are a family of actin bind- 
ing proteins that are ubiquitously expressed in all tis- 
sues and  cell  types,  although  specific  isoforms are 
characteristic  of particular cell types. TMs are encoded by 
multiple genes and TM expression is known to be regulated 
by transcriptional  and alternative RNA splicing mechanisms 
(see review by Lees-Miller and Helfman, 1991). In the rat, 
there are known to be 12 TM proteins expressed from three 
genes that likely arose through gene duplication  events. The 
a  TM gene codes for nine isoforms through  the use of two 
promoters and alternative  splicing mechanisms  (Ruiz-Opazo 
and Nadal-Ginard,  1987; Wieczorak et al., 1988; Lees-Miller 
et al., 1990; Goodwin et al., 1991). These isoforms include 
the skeletal muscle and smooth muscle c~ TMs (Ruiz-Opazo 
and Nadal-Ginard,  1987), the three brain isoforms TMBr-1, 
TMBr-2, TMBr-3 (Lees-Miller et al., 1990) and four fibro- 
blast isoforms TM-2, TM-3, TM-5a, and TM-5b (Goodwin 
et al., 1991). The/~ TM gene codes for two proteins by alter- 
native  splicing  (Helfinan  et al.,  1986)  producing  skeletal 
muscle/$-TM and fibroblast TM-1, which is also found in 
smooth muscle where it corresponds to the smooth muscle 
1. Abbreviations used in this paper: F-actin, filamentous  actin; IPTG, iso- 
propylthio-~-v-galactosidase; LRB, Lissamine rhodamine B sulfonyl chlo- 
ride; REE  rat embryo fibroblasts; TM, tropomyosin. 
/5-TM isoform.  The TM-4 gene produces a single protein, 
TM-4, which is produced in several cell types (Yamawaki- 
Kataoka  and Helfrnan,  1987; Lees-Milier et al.,  1990). 
The significance of this TM isoform diversity among mus- 
cle (skeletal,  cardiac,  and smooth) and nonmuscle ceils is 
not fully understood. The repertoire of different isoforms is 
largely conserved from chicken to rat to man, an evolution- 
ary span of more than 100 million years, suggesting that im- 
portant functions exist among the TMs that have been main- 
tained  by  selective  pressure.  This  is  exemplified  in  the 
conserved nature of the contraction mechanism of striated 
muscle where the expressed TM isoforms regulate, in associ- 
ation with the troponin complex, the highly ordered interac- 
tion  of myosin heads  and  actin  filaments  in  response  to 
stimulating calcium fluxes (Ebashi et al., 1969; see also Co- 
hen,  1975; Payne and Rudnick,  1989 for review).  In con- 
trast, although TM isoforms in smooth muscle and noumus- 
cle cells are largely conserved in various vertebrate species, 
the precise function  of these proteins is still unclear.  Since 
noumuscle and smooth muscle cells do not contain a tropo- 
nin complex, TMs must have a somewhat different role than 
in striated  muscle.  For example,  one possibility is that TM 
may stabilize actin filaments in noumuscle cells. This func- 
tion has also been inferred from in vitro experiments  which 
have  shown  that  TM protects  actin  filaments  against  the 
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et al., 1989) or the activities of brain depolymerizing factor 
(Bernstein  and Bamburg,  1982).  Other experiments have 
shown that the nonmuscle TMs prevent villin induced sever- 
ing (Mooseker et al., 1982) or bundling of F-actin (Burgess 
et al.,  1987),  but they  were unable to prevent  bundling 
caused  by  55-kD  protein  (Matsumura  and  Yamashiro- 
Matsumura,  1986).  Biochemical  studies  have  revealed 
differences in the properties of TMs isolated  from muscle 
(skeletal, cardiac and smooth) and nonmuscle cells. For ex- 
ample, in vitro functions of striated muscle TMs include the 
binding  of troponin T (Ebashi et al.,  1969); prevention  of 
destrin  induced F-actin  depolymerization (Nishida  et al., 
1985);  inhibition  of actin filament  depolymerization from 
the pointed end (Broschat, 1990; Weigt et al., 1990); and in- 
hibition of acto-myosin ATPase (Eaton et al., 1975). In con- 
trast, TMs from smooth muscle and nonmuscle cells bind 
poorly to troponin (Pearlstone and Smiliie,  1982) and have 
been  shown  to  enhance  the  skeletal  myosin  or  heavy 
meromyosin ATPase in vitro (Sobieszek and Small,  1977; 
Yama&~uchi et al., 1984). These differences between the bio- 
chemical properties of TMs from muscle and  nonmuscle 
cells suggest that each isoform will have a unique role in the 
respective cell types in which they are expressed. 
Why some cell types contain only one or two TM isoforms 
while others express multiple isoforms is unknown.  For ex- 
ample, rat fibroblasts contain at least six forms of TM, while 
skeletal muscle contains two isoforms, cardiac muscle a sin- 
gle isoform,  and  smooth muscle  contains  two isoforms. 
Microfilaments  of fibroblasts represent dynamic structures 
that  can  exist in  different  supramolecular  forms  such as 
microfilament  bundles (stress fibers), microfilament  mesh- 
works, polygonal networks, and contractile rings.  The par- 
ticular TM  isoforms involved  in these higher  order actin 
structures are poorly defined.  The multiplicity  of isoforms 
in fibroblasts  raises the possibility that specific associations 
of  given isoforms with themselves and other cellular proteins 
are required for distinct functions.  In nonmuscle cells TMs 
have been localized to actin filaments using both antibodies 
(Lazarides,  1975, 1982;  Warren  et al.,  1985;  Lin et al., 
1988)  or the microinjection of fluorescently labeled TMs 
from chicken smooth muscle, calf  brain, and skeletal muscle 
(Wehland  and Weber,  1980; Warren  et al.,  1985; Dome et 
al., 1988). Differences in the localization of  various isoforms 
have been demonstrated with antibodies recognizing only the 
high molecular weight TMs versus those recognizing  only 
the low molecular weight isoforms  (Lin et al.,  1988).  The 
low molecular weight forms were found in both ruffles and 
stress fibers  while the high molecular weight forms were 
found only in stress fibers. These differences in the distribu- 
tion of different  TM isoforms suggest  a distinct,  as of yet 
unidentified,  role for the various isoforms. 
In addition, one hypothesis that has been proposed is that 
changes in the relative levels of different TM isoforms in the 
cell may alter the organization  of microfilaments.  Accord- 
ingly, the alterations in microfilament structure and cell shape 
in transformed cells have been suggested to be the direct re- 
sult of  the altered patterns of  TM expression observed  in these 
cells (Matsumura et al.,  1983; Hendricks and Weintranb, 
1984; Cooper et al.,  1985; Lin et ai.,  1985). Moreover,  at 
least two reports have shown TM expression to return to nor- 
real levels in neoplastic cell lines which have spontaneously 
reverted to a nontransformed phenotype (Cooper et al., 1985; 
Fujita et al., 1990). However, at this time there is no direct 
evidence establishing a casual relationship  between changes 
in TM isoform expression and alterations in cytoarchitecture. 
Different biochemical properties have been reported for 
various nonmuscle  isoforms.  For  example,  studies  of rat 
fibroblast TMs demonstrated that a mixture of the low mo- 
lecular  weight  TM  isoforms  (termed  TM-4  and  TM-5) 
bound weakly to F-actin while the higher molecular weight 
isoforms (TM-1, TM-2, and TM-3) bound well (Matsumura 
and Yamashiro-Matsumura,  1985).  Similarly,  it has been 
shown that the low molecular weight TM isoform of equine 
platelets bound actin with low affinity (C6t~ et al., 1978) as 
does  the  low  molecular  weight  TM  isoform  of  brain 
(Broschat and Burgess,  1986). In contrast, however, the low 
molecular weight  TMs isolated from human erythrocytes 
(Fowler and Bennett,  1984) and chicken intestinal epithelial 
cells (Broschat and Burgess,  1986) have been shown to bind 
with much greater affinity, similar to high molecular weight 
isoforms.  These studies clearly indicate that different func- 
tional properties are a characteristic  of specific isoforms sug- 
gesting the possibility of distinct  functions in vivo. At pres- 
ent, few studies have addressed the function of TM isoforms 
in living cells. In vivo experiments which showed the alter- 
ation of intracellular  granule movement following  the mi- 
croinjection  of antibodies  to TM into chick fibroblasts have 
suggested  a function  in intracellular  motility  (Hegmann  et 
al.,  1989). 
All of the above evidence suggests fundamental  roles for 
TM  isoforms  in  maintaining  normal  cellular  activity  in 
different  cell types. An understanding  of the roles of this 
family  of actin-hinding  proteins would further our under- 
standing  of the cell cytoskeleton and  its  role in cellular 
processes. However, it has been difficult to study the bio- 
chemical properties of the individual  TM isoforms  due to 
their very similar physical and chemical properties, which 
makes their isolation from cellular sources difficult. In addi- 
tion,  the individual  isoforms have  not been available  for 
fluorescent modification to be used in microinjection  studies 
to determine their  localization  in vivo. Finally,  due to the 
conserved nature of many of the different  isoforms,  the in 
vivo localization  of TM isoforms by antibodies has been 
hampered by the fact that most antibodies detect more than 
one isoform. 
To begin to understand the function of the fibroblast TM 
diversity, we have prepared the individual isoforms using an 
Escherichia coli expression system in order to study the in 
vitro and in vivo properties of these proteins.  In this study 
four fibroblast isoforms, TM-2, TM-3, TM-5a, and TM-5b, 
products of the c~-TM gene, were expressed in a bacterial ex- 
pression system. We have found that both low (TM-5a and 
TM-5b) and high molecular weight TMs (TM-2 and TM-3) 
bind to actin filaments in vitro, although TM-Yo was capable 
of readily displacing the other isoforms from F-actin.  In ad- 
dition,  we have microinjected fluorescently labeled TM-2, 
TM-3,  TM-5a, and TM-5b into fibroblasts in order to see 
whether these isoforms behave differently  in vivo.  At the 
level of the light microscope all of the isoforms, despite their 
amino acid differences,  were found to incorporate into the 
same structures  of microfilaments.  There was no preferred 
cellular location or subset of actin filaments for any of these 
isoforms.  These results  suggest that these TM isoforms do 
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sets of actin filaments or locations in cells. These studies also 
show that bacterially produced fibroblast TMs can be used 
to study  in vitro and  in vivo properties of the proteins. 
Materials and Methods 
TM cDNA Clones and Expression Constructs 
The cDNA clones for rat fibroblast TM isoforms (TM-2, TM-3, TM-5a, 
and TM-Sb) have been described (Goodwin et al.,  1991). The coding se- 
quences for TM-5a and TM-5b were excised from SP64 plasmids using the 
TM NcoI site and a Hindrll site provided by the vector which was beyond 
the original DraI/HinclI insertion site. The HindIII site was filled in using 
Klenow fragment and BarnHI linkers added. The NcoI/BamHI fragment 
containing TM sequences was inserted into a NcoI/BamHI cut pET 8C ex- 
pression vector (Studier et al., 1990) to form plasmids pET TM-5a and pET 
TM-5b.  Expression plasmids pET TM-2  and pET TM-3  were made by 
utilizing another cDNA plasmid, SP64 TM-2, which contains the full cod- 
ing sequence for TM-2. The NcoI/SacI fragment of TM-2 containing amino 
acids 1-234 was isolated and ligated into either pET TM-5a or pET TM-5b, 
with the respective NcoI/SacI fragment removed. Amino acids 235-284 
were provided by the pET TM-5a or pET TM-Sb plasmids, thus recon- 
structing TM-2 and TM-3 in the pET vector. The relationships of these ex- 
pression plasmid constructs to each other and the cc gene coding sequences 
are shown in Fig. 1 a. The predicted molecular weights for full length pro- 
teins are 32710 for TM-2, 32849  for TM-3, 28558 for TM-5a, and 28697 
for TM-5b. 
Purification and Characterization  of TM Proteins Pro- 
duced in Bacteria 
The pET 8C expression system (Studier et al., 1990) uses an inducible T7 
RNA polymerase to drive transcription of  the protein of interest. The cDNA 
clone for the protein is inserted into the pET plasmid just downstream of 
the T7 promoter element. We have used the E.  coil B  strain BL21  (F-, 
ompt, rB-, mB-) harboring a DE3 lysngen with an IPTG inducible T~ poly- 
merase as host for Tm protein production. Bacteria for protein production 
were grown at 37~  in M9ZB media (10 g/1 Bacto lYyptone, 1 g/l NI-hC1, 
3 g/l KH2PO,, 6 g/l Na2HPO4, 4 g/l glucose, 1 ml/1 1 M MgSO4,  100 mM 
ampicillin) (DIFCO Laboratory, Detroit, MI) and induced when the OD600 
was 0.8-0.9 by the addition of 0.1  g/l of isopropylthio-/~-D-galactosidase 
(IFR3)  (Bethesda Research Laboratories,  Gaithersburg,  MD).  Bacteria 
were incubated for 2-4 h further. Before induction, the fraction of cells car- 
lying the inducible plasmid was determined as described (Studier et al., 
1990) and found to be 97-99%. The plasmids appear to have no toxic effects 
on the normal growth of the bacteria. Bactria were stored frozen in media 
with 50%  glycerol at  -70~ 
After induction, the bacteria were pelleted and washed once with PBS. 
Bacteria were resuspended in 30 ml of 50 mM Tris, pH 7.5,  100 mM KCI, 
5 mM ED'rA, i  mM D'Fr, 100 ~g/ml PMSF,  1 p.g/ml aprotinin, 1 #g/ml 
leupeptin,  1 ~g/ml pepstatin, and lysozyme was added to  1 mg/ml. The 
robes were incubated on ice for 20 rain and then frozen for 30 rain at -70~ 
Upon thawing, 3 ml of 10% Triton X-100 was added and the samples mixed 
gently for  15  rain at  room temperature.  Samples were spun in a  rotor 
(SW28;  Beckman Instruments Inc., Palo Alto, CA) at 25,000 rpm for 2 h 
at 4~  The supernatant was decanted and the pelleted debris discarded. All 
of the TM isoforms were expressed in BL21 (DE3) bacteria as soluble pro- 
teins. TMs were present as 10-30% of the total cellular proteins as deter- 
mined by gel scanning of Coomassie blue-stained gels. The TM protein was 
then purified using ammonium sulfate fractionation followed by resuspen- 
sion in 0.1 M KC1, 25 mM Tris-Cl, pH 7.5, and overnight dialysis versus 
the same buffer. TM-3 and TM-5b precipitated at 25-55 % ammonium sul- 
fate whereas TM-2 and TM-5a precipitated at 30-65% ammonium sulfate. 
The TMs were then pH precipitated at their isoelectric point by adding so- 
dinm acetate, pH 4.5, to 20 mM final concentration and the samples allowed 
to sit on ice for 20 min, followed by centrifugation (15 rain, 4,500 rpm, 4~ 
(H6000 rotor; Sorvall Instruments, Newton, CT). Pellets were resuspended 
in ",,30 ml 0.1 M KCI, 25 mM Tris-Cl, pH 7.5. Solid KCI was added to 1 M 
KCI and after dissolving, the solution was placed in a water bath at 95~ 
for 10 rain. Any denatured proteins were pelleted by centrifugation (Sorvall 
RC3B;  15 rain, 4~  and the TMs which remained in solution were recov- 
ered by pH precipitation. Alternatively, for large scale preparations, the 
Table L NHz-terminal Sequencing 
TM-2  TM-3  TM-5a  TM-5b 
Cycle 
1  M  51.7  M  2.3  A  90.0  A  134.4 
2  D  47.1  D  8.7  G  67.1  G  159.2 
3  A  45.7  A  15.1  S  16.9  S  27.4 
4  I24.0  I  8.1  S  15.0  S  31.6 
5  K33.1  K  4.8  S  8.1  S  21.6 
6  K  41.7  K  7.6  L  39.2  L  62.6 
7  K  38.2  K  7.4  E  12.9  E  29.8 
8  M  40.9  M  6.7  A  37.2  A  56.3 
heat treatment step followed by pH precipitation was used before AS frac- 
tionation with similar final results. Anion exchange chromatography was 
carried out using Q Sepharose Fast Flow (Pbarmacia Fine Chemicals, Pis- 
caraway, NI) and a gradient of 50 to 450 mM sodium chloride containing 
25 mM Tris, pH 7.5,  1 mM DTT.  The fractions were analyzed by elec- 
trophoresis on 12% polyacrylamide gels containing SDS-PAGE using de- 
scribed conditions (Laemmli, 1970) and selected fractions were pooled and 
pH precipitated. Before the TMs were used in subsequent experiments, they 
were prebound to F-actin to insure that they were 100%  active. For this, 
TMs were incubated with F-actin for 1 h in a buffer containing 100 mM 
KCI, 20 mM sodium phosphate, pH 7.0, and 0.5 mM DTT. The F-actin and 
associated TM was pelleted by centrifugetion in a Beckman Airfuge (Beck- 
man Instruments, Palo Alto, CA) at 28 psi. The supernatants were removed 
and the pellets resuspended in the same buffer. After resuspension, the con- 
centration of KCl was increased to 0.4 M and the samples warmed to 65~ 
for 10 rain to denature the actin, which was then pelleted by centrifugation 
in a microfuge at 14,000 rpm and the TM was recovered from the superna- 
rant by pH precipitation as described above, and then resuspended in 0.1 M 
KCL, 20 mM sodium phosphate, pH 7.0, 0.5 mM DTT, and the pH adjusted 
to neutral pH with 0.25  M NaOH. 
NHrterminal Sequencing 
NH2-terminal sequencing was carried out at the Protein Core Facility at 
Cold Spring Harbor Laboratory (Cold Spring Harbor, NY) essentially as 
described (Matsudaira,  1987).  Briefly, TM isoforms were electrophoresed 
on a  12% polyacrylamide gel and electroblotted to polyvinylidene difluo- 
ride membranes (Millipore Corp., Bedford, MA) in 10% methanol, 10 mM 
3-(cyclohexylamino)-l-propanesulfonic  acid (CAPS), pH 11.0. Membranes 
were lightly stained with Coomassie blue, 0.1% in 50% methanol, and the 
bands of interest were excised for gas phase sequencing on an Applied Bio- 
systems 475 machine (Foster City, CA) using on line PTH derivatization 
and subsequent high-pressure liquid chromatography on an ABI 120A ma- 
chine (Applied Biosystems Inc.) No blocked termini were present and se- 
quencing was carried out for 8 to 18 cycles. Results of the first eight cycles 
are shown in Table  I, with the yield in pmol for each cycle. 
COOH-terminal Sequencing 
The amino acid sequences of the carboxy termini oft,g0 of the TM isoforms 
were determined by the time course of  amino acids released during digestion 
with carboxypeptidase Y. A solution (20 micromolar) of purified TM con- 
taining 20 micromolar proline, which is not present in the TM isoforms, 
as internal standard was digested with 0.6 /~g/rnl of carboxypeptidase Y 
(Boehringer-Mannheim Biochemicals, Indianapolis, IN) in 0.1 M sodium 
acetate, pH 6.0, at 25~  Samples of 10 #i were removed at 0,  1, 5,  15, and 
30 rain, 1, 2, 4, and 6 h and mixed with 10 ~tl concentrated acetic acid to 
stop the reaction and then frozen. Samples were dried in a Speed-Vac and 
then prepared for amino acid analysis by derivatization with PITC and ana- 
lyzed on an amino acid column (Waters,  Inc., Danvers, MA). The results 
are shown as relative molar amounts in Table  II. 
Filamentous Actin Binding Assay 
Bacterially produced tropomyosins were tested for their ability to bind to 
filamentous actin (F-actin) using an in vitro sedimentation assay essentially 
as described (Matsumura and Yamashiro-Matsumura, 1985) in a buffer con- 
raining 100 mM KCI, 20 mM sodium phosphate, pH 7.0, and 0.5 raM I31"T. 
Routinely,  incubations  were  for  1  h  at  room temperature  followed by 
Pittenger and Helfman Characterization of Fibroblast Tropomyosins  843 Table II. COOH-terminal Sequencing 
Min  M  N  N  L  L  E  L 
TM-2  1  0.86  .... 
15  0.92  0.82  0.71  0.34  - 
30  1.0  1.56  1.2  0.39  - 
60  1.1  1.25  1.27  0.45  - 
TM-5b  1  0.47  -  -  - 
15  0.92  0.65  0.59  0.15 
30  1.0  1.31  1.41  0.33 
60  1.05  1.61  1.91  0.43 
sedimentation in an airfuge (Beckman Instruments) at 28 psi for 30 min (at 
room temperature).  All of the binding assays were performed using TMs 
that were prebound to F-actin as described above to avoid denatured or non- 
binding  proteins in the final preparations. F-ectin concentration  in the assays 
was routinely  1 mg/ml while the TM concentration was varied from 0.015 
to  1 mg/mi.  Acetone powder  from rabbit skeletal muscle was prepared 
(Pardee  and Spudich,  1982)  and stored at  -20~  and used  for actin 
purification by the method of Pardee and Spudich (1982). F-actin prepared 
by a similar procedure was also obtained as a generous gift of Dr. Leonard 
Stein (Department of Cardiology,  State University of New York, Stony- 
brook, NY). Rabbit skeletal muscle TMs (c~ and/3 isoforms) were prepared 
as described (Smillie,  1986). Protein determinations were originally done 
by amino acid analysis  on the purified  proteins and subsequently by the 
method of Lowry et al. (1951) using bovine serum albumin as the standard. 
Fluorescent Labeling of TM Isoforms 
FITC and Lissamine rhodamine B sulfonyl chloride (LRB) were obtained 
in 10 rng packaging from Molecular Probes Inc. (Eugene, OR). Fluorescent 
labeling of purified TM isoforms was carried out as described below based 
on the methods used for immunoglobulins  (Brandtzaeg,  1975). Briefly, FITC 
was dissolved in N,N-dimethylformamide  to 50 mg/ml and 2 #1 was added 
to 2 mg of TM isoform in 1 ml of 0.3 M sodium carbonate, pH 9.0, and 
0.1  M  potassium chloride.  The sample was  stirred on ice for 4  h  and 
quenched with a molar excess of glutamine. Free dye was removed by chro- 
matography on a 1 ￿  20 cm Sephadex G-25 (Pharmacia Fine Chemicals) 
column equilibrated with 0.1 M potassium chloride,  20 mM sodium phos- 
phate, pH 7.0. The labeled TM protein in the void volume was collected and 
pH precipitated by the addition of 1 M potassium acetate pH 4.6 to 20 mM 
and the protein collected by centrifugation  in a microcantrifuge  at 4~  and 
14,000 g for 5 rain. The protein was then resuspended in 300-500/~1,  0.1 M 
KC1, 20 mM sodium phosphate, pH 7.0, and adjusted to neutral pH with 
1 M  NaOH and applied to a second G-25 column. The labeled TM was col- 
lected as above and resnspended in 100 mM KCI, 20 mM sodium phos- 
phate, pH 7.0, and 0.5 mM DTT, and brought to neutral pH. For labeling 
of isoforms with LRB, the dye was dissolved in acetone at 10 mg/mi and 
30 ~1 was used to label 2 rag of protein for 20 rain on ice with stirring.  The 
reaction was stopped and proteins recovered as above. Dye to protein ratios 
were  determined using the relationship d/p  =  MJconcentration  ￿  OD 
dye/extinctiun coefficient and the molar extinction coefficients of 76,000 and 
34,000 for FITC and LRB, respectively. Reaction times were varied slightly 
in these reactions to yield a dye to protein ratio of I to 1.5 for the labeled 
isoforms that were used for microinjection. The samples were then brought 
to neutral pH and dialyzed against the actin binding buffer. The labeled pro- 
teins were then prebound to F-actin and found to bind to F-actin quite simi- 
larly to the unlabeled proteins. For most microinjection experiments,  the 
prebound LRB labeled TM isoforms were routinely used. The labeled TMs 
were stored on ice and normally used within one week. 
Cell Culture Methods 
Cultured rat embryo fibroblasts (REF 52) were grown in DME (Gibco BRL) 
containing 10%  Rhehatuin fetal  calf serum (Intergen,  Purchase,  NY), 
4,500 rag/1 glucose, 50 mg/l streptomycin,  50 U/rni penicillin G. Cells were 
grown in a 5% CO2 atmosphere at 37~ 
Microinjection of Fluorescently Tagged Isoforms into 
Cultured Cells 
Cultured  cells  were  grown  on  gridded  glass  coverslips  (Bellco  Inc., 
Vineland, NJ) in normal growth medium for 36-48 h before use. Cells were 
needle  microinjected  using  published procedures  (Diacumakos,  1973; 
Graessman et al.,  1980).  Micropipets  were pulled on a  vertical puller 
(model 720; David Kopf Instruments, E1 Cajuns, CA) from I mm OD thin 
walled glass capillaries with internal filament (WPI Inc., Hew Haven, CT). 
During injections,  ceils were kept in normal medium (without serum) sup- 
plemented with HEPES to 25 mM, pH 7.0, to maintain pH. Temperature 
was maintained at 37~  using a stage warming block designed to hold 60 
nun dishes or culture chamber (constructed by M.E Pittenger).  Purified la- 
beled TMs to be injected were first dialyzed vs. 100 mM KC1, 20 mM so- 
dium phosphate, pH 7.0, centrifuged at 140,000 g for 20 min and the protein 
concentrations then determined. The cells were microinjected with a TM 
concentration of 2-5 mg/ml and an amount equal to 5-10% of the cell vol- 
ume. This is estimated to increase the amount of a given TM isoform sever- 
alfold. Micropipets were filled from the back end by capillary action. After 
injection cells were incubated for 2-4 h (unless otherwise stated) in a CO2 
incubator before fixation. 
For fixation,  coverslips  of injected cells were rinsed in a cytoskeletai 
stabilizing  buffer (4 M glycerol,  10 mM EGTA,  I mM MgC1, 25 mM Pipes, 
pH 6.9) and then incubated in the same buffer containing 0. 2 % Triton X-100 
for 5 rain at room temperature to allow unincorporated proteins to diffuse 
away. The cells were then fixed for 40 rain in freshly made 4 % formaldehyde 
(from base hydrolysis of paraformaidehyde;  Folysciences Inc., Warrington, 
PA) in PBS, pH 7.0. The coverslips were then thoroughly rinsed with PBS 
and PBS containing 100 mM glycine  to quench any remaining reactive 
formaldehyde. Where stated, the cells were then treated with primary mAbs 
(Tin 311; Sigma Chemical Co., St. Louis, MO) in PBS for 40 rain, washed 
in PBS (3  x  5 rain at room temperature) and fluorescent  secondary goat 
anti-mouse antibodies (Cappel Laboratory, West Chester,  PA) applied for 
40 rain, followed by PBS washes.  Alternatively,  cells were counterstained 
with FITC-phalloidin (Molecular Probes Inc., Eugene,  Oregon)  to stain 
F-actin in some experiments.  Fluorescence microscopy  was accomplished 
with a Zeiss Axiophot using either 40￿  water immersion, 63￿  0.4 NA), 
or 100￿  0.2 NA) objective lenses (Carl Zeiss Instruments, Inc., Thorn- 
wood,  NY).  Images  were  recorded on Kodak 400 or P3200 Tmax film 
(Eastman Kodak,  Co., Rochester,  NY) developed  according to manufac- 
turer's instructions. 
Results 
Preparation and Characterization of 
Bacterially Produced TMs 
To prepare homogeneous preparations of  rat fibroblast TM-2, 
TM-3, TM-5a, and TM-5b, the eDNA for each isoform was 
inserted  into the pET 8C expression vector (Studier et al., 
1990). These vectors allow full-length  proteins  to be made 
starting with the ATG codon of the eDNA and the products 
therefore contain only TM encoded amino acids.  The pET 
8C vector is shown in Fig.  1 B. The eDNA clones corre- 
sponding to the four fibroblast, gene products (see Fig.  1 
A) were cloned into pET 8C using the naturally  occurring 
NcoI site at the initiating codon and a BamHl site introduced 
59-bp downstream  of the stop codon in the 3'-untranslated 
region. These cDNAs have been previously described (Good- 
win et al.,  1991). The TM proteins were purified from the 
bacterial  lysates using  modifications  to those methods de- 
scribed for isolation  of tropomyosin  from tissue  (Bailey, 
1948; Bourdillon and Baker, 1956; see Materials  and Meth- 
ods).  The proteins were analyzed  biochemically by SDS- 
PAGE, amino acid analysis, amino- and carboxy-terminal se- 
quence analysis,  and their ability to bind to F-actin. 
The bacteria produced the soluble TM isoforms constitu- 
tively but levels were further increased by induction  with 
IPTG. An example of the SDS-PAGE results of the crude ly- 
sates  is shown  in Fig.  2 A.  The  addition  of IPTG to the 
growing cultures in early log phase is indicated by the plus 
(+) sign.  The arrowheads  indicate the TM isoforms which 
were of the expected size for full-length proteins.  Represen- 
tative samples of the purified  TMs are shown in Fig.  2 B. 
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Figure 1. Diagram of  the fibro- 
blast TMs from the rat a-TM 
gene and the pET-SC bacterial 
expression plasmid.  (A)  Rat 
fibroblast TM isoforrns  TM-2, 
TM-3, TM-5a, and TM-5b are 
encoded by the ce gene. The 
fibroblast isoforrns TM-2 and 
TM-3  arc  transcribed  using 
the  promoter  upstream  of 
exon  la,  while  TM-SA and 
TM-5B use the internal pro- 
moter upstream  of exon  lb. 
Exon 6b is used in TM-2 and 
TM-5a while exon 6a is used 
in TM-3 and TM-5b. The sol- 
id boxes denote exons which 
are  common  to  all  ce  gene 
products. TMs 2,  3, 5a,  and 
5b all use exon 9d and the last 
poly A addition  site (identi- 
fied by the A).  These fibro- 
blast isoforms have identical 
amino acid sequences for ex- 
ons 3 through 5 and 7 through 
9.  See Goodwin et al.  0991) 
for details. (B) Diagram of  the 
pET 8C bacterial expression plasmid showing the pertinent regions. The gene for 1"7 RNA polymerase is present in the host BL 21 bacte- 
ria as part of the lysogenic bacteriophage X derivative DE3. Its expression is under the control of the/acUV5 promoter which is inducible 
with IPTG. The 1"7 polymerase is highly specific for ~10 promoter. See Studier et al. (1990) for details. 
Densitometry of the Coomassie blue stained gels revealed 
93-97% of the protein in each lane was present as a band 
of the appropriate molecular weight  for full-length TMs. 
Faint bands could be seen near the major band and may rep- 
resent modified species. The right hand lane of Fig. 2 B con- 
tains  partially  purified  TMs  isolated  from  cultured  rat 
fibroblasts, the numbers to the right indicate  the identity of 
the endogenous TM isoforms. Bacterial TM-2 and TM-3 ap- 
pear  to  comigrate  with  their  counterparts  isolated  from 
fibroblasts,  while TMs 5a and 5b  from bacteria exhibit a 
slightly faster mobility. It is unlikely that this is due to some 
posttranslational modification or processing occurring in the 
bacteria as in vitro transcription and subsequent translation 
in a rabbit reticulocyte extract yielded TMs with these same 
mobilities. Although TMs in fibroblasts are not known to be 
modified, this remains a possible explanation. 
Amino-terminal sequencing was carried out on the full- 
length products to determine 8--18 amino acids of these pro- 
teins (see Table I, Materials and Methods). All bands were 
readily sequenced by Edman degradation and found to have 
an unblocked amino terminus corresponding to the correct 
sequence, but in the cases of TM-5a and TM-5b, the ini- 
tiating methionine had been removed. Thus, for TM-2 and 
TM-3 the methionine was retained, while for TM-5a and 
TM-5b, the penultimate alanine residue was the terminus. 
Although these isoforms have not yet been sequenced from 
cellular sources, the equine platelet TM, another of the low 
molecular weight  isoforms  (247  amino  acids),  was  also 
shown to have the methionine removed (C6td et al.,  1978). 
We also used carboxypeptidase Y to determine the sequence 
of the carboxy terminus of the isoforms (see Table II, Mate- 
rials and Methods). By the time course of the amino acids 
released, the sequences were determined to be correct for 
full-length TM isoforrns.  The amino acids determined for 
the amino- and carboxy termini for the various TMs are 
given in Table III. 
Bacterially Produced TMs Bind F-actin In Vitro 
To further characterize the biochemical properties of the 
bacterially  produced  TMs,  their  ability  to  bind  and  co- 
sediment with F-actin was tested.  For this,  isoforms were 
first  prebound  to  F-actin  and  repurified as  described  in 
Materials  and Methods to assure  that the added TM was 
completely active. Decreasing concentrations of each TM 
isoform  were  incubated  with  a  fixed amount  of F-actin 
purified from rabbit skeletal muscle. The samples were cen- 
trifuged and tropomyosin co-sedimenting with the F-actin, 
as well as that remaining in the supernatant, was resolved on 
12% SDS-polyacrylamide gels. The binding of the TM iso- 
forms  produced  in  bacteria  was  also  compared  to  TMs 
purified from rabbit skeletal muscle (or and/3 skeletal iso- 
forms, products of the c~ and/3 genes,  respectively). The 
Coomassie blue-stained gels were quantitated by densitom- 
etry and compared with  standard  curves generated using 
known amounts of TM isoforms. Association constants were 
determined  using  the  TM  dimer  molecular  weights  of 
65,420, 65,698, 57,116, and 57,394 for TM-2, TM-3, TM-5a, 
and TM-5b, respectively. Examples of the results are shown 
in Fig. 3. All four of the fibroblast TMs (TM-2, TM-3, TM- 
5a and TM-5b) were found to bind to F-actin under these 
conditions.  They did not  sediment when F-actin was  not 
present (data not shown but see Fig.  4, A and B, lane 5). 
Without the pre-binding to F-actin, TM-2, TM-3, and TM- 
5b were found to bind with an affinity comparable to the rab- 
bit skeletal TMs (Fig. 3, A, B, C, and E). However, the TM- 
5a isoform did not bind as well as the other isoforms (Fig. 
3 D) but eventually did show saturation binding at high con- 
Pinenger and Helfman Characterization of Fibroblast Tropomyosins  845 Figure 2. Induced expression of fibmblast TMs in E. co//and the purified isoforms. (A) The expression of the TM isoforms in the pET 
vector was constitutive, but could be induced to higher levels with IPTG. 1 ml of log growth culture was taken before induction with IPTG 
(- lanes) and 2 h after its addition (+ lanes). The bacteria were centrifuged and the pellet then lysed directly in 100/~1  of SDS gel sample 
buffer. 10 td of  each sample was loaded onto a 12 % gel. In B, 2 ttg of the purified isoforms were resolved on a 12 % SDS gel. For comparison, 
the lane marked TM contains the partially purified TMs of a fibroblast cell line, with the respective isoforms indicated to the fight. 
centrations (above 25/~m dimer, data not shown). Therefore, 
the TM-5a sedimenting with F-actin was purified and used 
in a subsequent actin-binding assay.  As shown in Fig. 3, F 
and G, the amount of TM-5a bound to actin was similar to 
Table III. Sequence of NHz and COOH Terminus of 
Bacterially Produced TMs 
Isoform  Amino termillus  Carboxy termirltls 
TM-2  MDAIKKKM-  -(LLEL) NNM 
TM-3  MDAIKKKMQML-  Not determined 
TM-5a  AGSSSLEAV-  Not determined 
TM-5b  AGSSSLEAV-  -(DQT)LLELNNM 
the other isoforms, suggesting that the original results with 
TM-5a were due to a heterogeneous protein population. Iso- 
forms 2,  3,  and 5b did not show a  significant increase in 
F-actin afnnity when such a prebinding step was included 
(data not shown).  However, for consistancy, each of these 
was also prebound and repurified for use in the remaining 
experiments in this study. Binding assays with isoforms pre- 
bound to F-actin revealed the expected cooperativity and ap- 
parent K,s of 5/tM for TM-2, 3.5/~M for TM-3, 3.0/~M for 
TM-5a, 2.0 ~M for TM-5b. 
TM-$b Is Better than TM-Ja in Displacing Other 
Isoforms  from  F-actin 
The  differences  in  the  amino acid  sequence  between TM-5a 
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bacterially produced TMs; comparison 
with rabbit  skeletal  muscle  TMs.  De- 
creasing concentrations of purified iso- 
forms of TMs  2,  3,  5a,  and  5b were 
tested  for their ability to bind to 1 rag/ 
ml  of rabbit  skeletal  muscle  F-actin. 
Lanes 1 through 6 represent concentra- 
tions of 1, 0.75, 0.50, 0.25, 0.125 and 0.06 
mg/ml, respectively.  F-actin and bound 
TM were sedimented  in a Beckman Air- 
fuge  and  supernatants  and  pellets  re- 
solved  on a  12%  SDS-polyacrylamide 
gel and  stained  with  Coomassie blue. 
Only the pellets are shown here. TM-2, 
TM-3, and TM-5b were found to bind 
with similar high affinity, comparable to 
skeletal TMs (a and/3, <> on graph). As 
purified,  TM-Sa  (D  and  x  on  graph) 
was found to bind with a lower affinity 
than the other isoforms. However, when 
TM-Sa was first bound to actin at saturat- 
ing concentrations and then sedimented 
and repurified  and used in the binding 
assay, it bound with an affinity  similar 
to the other isoforms (see F  and ￿9  on 
graph).  Subsequently,  all  of the  TMs 
were prebound to F-actin and repurified 
before further experiments.  G shows the 
results of binding assays using prebound 
isoforms to determine the apparent Kis 
which were 5/zM for TM-2, 3.5/zM for 
TM-3,  3.0 ~M for TM-Sa, 2.0/~M  for 
TM-Sb, and 2.5/~M for rabbit skeletal 
muscle TM. 
and TM-Sb (due to the use of exons 6a or 6b, see Fig.  1) has 
led to the hypothesis that TM-Sb would bind actin filaments 
with a higher affinity than TM-Sa (Goodwin et al.,  1991; see 
Discussion below).  To determine whether TM-Sa and TM- 
5b have different affinities for F-actin in vitro,  we analyzed 
their relative ability to displace TM-2 from actin filaments. 
Isoforms TM-2, TM-5a, and TM-5b were each prebound to 
F-actin  and  repurified.  F-actin  was  pre-incubated  with 
saturating  amounts  of  TM-2  for  30  min  and  increasing 
amounts of either TM-Sa or TM-5b were added for an addi- 
tional 60 min. The F-actin bound TMs were then pelleted by 
centrifugation  and  the  proteins  in  the  supernatants  and 
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TM-Sa at displacing TM-2 from F-actin. 
TMs were first prebound to F-actin and 
repurified. A constant amount of F-actin 
(1 mg/ml or 23 t~M) was then incubated 
with a constant saturating amount of TM-2 
(0.5  mg/ml  or  15  ~M)  for  30  min  at 
room temperature.  Decreasing amounts 
of TM-5a (A) or TM-5b (B) were added 
for an additional hour and the F-actin with 
associated  TMs  pelleted.  Supernatants 
and pellets were  then resolved by  12% 
SDS-polyacrylamide gels. The superna- 
tants are shown in lanes 1-6 and the pellets 
are in lanes 7-12.  Lanes 1 and 7, 26 #M 
(0.75 mg/ml); lane 2  and 8,  17 #M (0.5 
mg/rnl); lanes 3 and 9, 8.7 #M (0.25 mg/ 
ml); lanes 4and 10, 4.3 #M (0.125 mg/ml); 
lanes 5 and 11, no actin, 15 #M TM-2, 17 
#M  TM-5a,  or  TM-5b  (residual dena- 
tured actin in A, lane 5  is from the pre- 
binding step); lanes 6 and 12, no Tm-5a 
(A) or TM-5b (B). 
Figure  5.  TM-5b  efficiently displaces 
TM-3 or skeletal muscle TMs. Similar 
to  Fig.  4,  F-actin (1  mg/ml)  was  in- 
cubated  with  saturating  amounts  (0.5 
mg/ml) of TM-3 (A), TM-2 (B) or skele- 
tal muscle TMs (C) for 30 min at room 
temperature and then decreasing amounts 
of TM-5b (A and C) added for an addi- 
tional hour. To compare TM-2 vs. TM-3 
binding (B),  0.5  mg/ml of TM-2  was 
added for 30 min and decreasing amounts 
of TM-3 added for an additional hour. 
F-actin and associated TMs  were pel- 
leted and the supernatants and pellets 
resolved  on a 12 % gel. The supernatants 
are shown in lanes 1-6 and the pellets in 
lanes 7-12. Lanes I and 7, no second TM 
added; lanes 2 and 8, 0.75 mg/ml second 
TM;  lanes 3  and 9, 0.5 mg/ml second 
TM;  lanes 4  and 10,  0.25  mg/ml sec- 
ond TM; lanes 5  and//,  0.125  mg/ml 
second TM; lanes 6and 12, 0.062 mg/ml 
second TM.  TM-5b,  at equal concen- 
tration, readily displaced TM-3 or the 
skeletal muscle TMs.  However TM-3 
did not readily displace TM-2. 
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mine B. Fibroblast TM isoforms produced in bacteria were purified 
and labeled with Lissamine rhodamine B as described in Materials 
and Methods. The fluorescently labeled proteins were separated 
from unincorporated dye by column chromatography and pH pre- 
cipitation.  The dye to protein ratio was determined (varied from 
1.1-1.3 in these samples) and 3/zg of each labeled protein was run 
on a 12 % polyacrylamide gel. The gel was first photographed under 
UV illumination (lanes a, b, c, and d) and then stained with Coo- 
massie blue and photographed on a light box (lanes A, B, C, and 
D). Labeled TM-2 was run in lane A (a), TM-3 in lane B (b), TM- 
5a in lane C (c), and TM-5b in lane D (d). Molecular weight mark- 
ers are shown to the right. 
pellets resolved by SDS-PAGE. The results are shown in Fig. 
4 with the supernatants shown in lanes 1-6 and the pellets 
in lanes 7-12 (see legend for details). TM-5b was more effec- 
tive in binding and displacing TM-2 from actin. TM-5b, at 
8.7/~M displaced >50% of the bound TM-2 in the presence 
of saturating amounts of TM-2, while TM-5a was much less 
effective. With 8.7 #M TM-5a, only 10-20% of the TM-2 
was displaced.  This experiment was performed four times 
with two preparations of each isoform and gave the same 
results. These results indicated TM-5b had a greater affinity 
than TM-5a for F-actin. TM-5b was also tested for its ability 
to displace TM-3 or TMs prepared from skeletal muscle 
(containing a mixture ofoe and/~ skeletal TMs) from F-actin. 
As shown in Fig. 5, A and C (supernatants in lanes 1-6 and 
pellets in lanes 7-12), TM-5b was quite efficient  at displacing 
TM-3 or the skeletal muscle TMs. In displacing the skeletal 
muscle TMs, TM-5b did not preferentially displace either 
the ct or fl isoform, but displaced them with equal efficiency. 
We also tested the relative ability of  TM-3 to displace TM-2. 
These two isoforms differ only in the 24 amino acid exon that 
also constitutes the difference between TM-5a and TM-5b 
(see Fig. 1). As shown in Fig. 5 C, these two isoforms bound 
to F-actin with similar affinities and TM-3 did not displace 
TM-2 with the efficiency that TM-5B displaced other TMs. 
Fluorescent Derivatization and Microinjection 
of TM Isoforras 
To determine whether the functional significance of the mul- 
tiple fibroblast TM isoforms may be related to differences in 
their intracellular localization, each of the bacterially pro- 
duced TMs was fluorescenfly labeled and introduced into 
cultured fibroblasts by microinjection. Each isoform was la- 
beled in separate reactions with amine reactive fluorophores 
LRB and FITC.  The reaction conditions were adjusted to 
yield a dye to protein ratio of 1 to 1.5. Examples of the LRB- 
labeled isoforms are shown in Fig. 6. The labeling procedure 
did  not  significantly alter the  binding  of the  isoforms to 
F-actin in the binding assay (data not shown).  Cultured rat 
embryo fibroblasts (REF 52 cells) were microinjected with 
the fluorescenfly labeled TMs and the cells were returned to 
the incubator for up to 4 h to allow the proteins to equilibrate 
with the endogenous pools and incorporate into the actin 
cytoskeleton.  TM  incorporation  into  the  microfilaments 
could be seen as early as  10 min after injection and was 
nearly complete throughout the cytoskeleton in 30--40 min. 
There was not a detectable difference in TM incorporation 
at the cell periphery compared to the perinuclear region sug- 
gesting  the  dynamic incorporation occurs  along  the  fila- 
ment's length rather than at the ends (data not shown). An 
example of a living cell microinjected with fluorescent TM- 
5b and showing incorporation into the actin cytoskeleton is 
Figure 7. Distribution of microinjected TM-5b is quite similar in living and fixed cells. To show that the labeled TMs were associated 
with the microfilament system before fixation procedures and not as a consequence thereof, cells were microinjected and photographed 
with fluorescent optics while living (A) and following fixation (B).  Note that the same structures are labeled and that the resolution is 
enhanced by extraction and fixation. 
Pittcnger and Helfman Characterization  of Fibroblast Tropomyo$ins  849 Figure 8. Microinjection of fluorescently  labeled TM-2. A, (7, and E show cells microinjected with LRB-TM-2. In A, TM-2 can be seen 
in the long cellular process as well as the cell body. An uninjected neighboring cell is also seen in the phase image in B. TM striations 
can be seen in well spread cells (arrows in C) which are not seen in FITC-phalloidin-stained microfilaments  (D). The arrowheads point 
to the edges of the cell where TM-2 is present.  E shows the injected  TM-2 viewed  in the rhodamine channel while F  shows the same 
field with cells stained by TM antibodies  and a fluorescein  labeled secondary antibody. 
shown in Fig. 7 A and labeling of microfilaments are clearly 
visible.  The ceils  on this  coverslip were  subsequently  ex- 
tracted with a low concentration of non-ionic detergent in a 
cytoskeletal  stabilizing buffer to allow the unincorporated 
proteins to diffuse out. The ceils were then fixed with freshly 
prepared  formaldehyde in PBS,  mounted and observed by 
fluorescence microscopy. Fig. 7 B shows the same cell as in 
Fig.  7  A  after  fixation and the  filaments  are more clearly 
seen.  Detectable labeIing of microfilaments was present as 
late as 48 h after microinj ection, although the intensity of  the 
The Journal of Cell Biology, Volume 118, 1992  850 Figure 9. Microinjection of fluorescently labeled TM-3. Examples of REF 52 cells microinjected with LRB-TM-3 are shown in A, C, and 
E. B, D, and F show the corresponding phase (B) or FITC-phalloidin-stained fields (D and F). TM-3 is found out to the edge of the cell 
and in edge ruffles (arrowheads). The cells shown here do not show well developed striations in the fluorescent TM-3 labeled microfilaments 
although other examples have shown them. D shows the neighboring uninjected cells labeled with F1TC-phalloidin. 
fluorescence had declined greatly. In all cases, the microin- 
jection of TM had no detectable effects on the morphology 
of the cells over the time period they were observed. 
Bacterially Produced TMs Bind to Microfilaments 
In Vivo 
Fluorescently labeled TM-2 was microinjected into REF 52 
cells and typical results are shown in Fig.  8. Fig.  8, A,  C, 
and E  show the distribution of the  Lissamine rhodamine 
B-labeled TM-2. Fig. 8 A is an example of TM-2 present in 
long cellular extensions. Fig. 8 B is a phase image of  A show- 
ing the injected cell and a nearby uninjected cell. In Fig. 8 C, 
the arrowheads show TM-2 present in small ruffles at the cell 
periphery. There are striations present in many of the fila- 
Pittenger and Helfman Characterization of Fibroblast Tropomyosins  851 Figure 10. Labeling of microfilaments in fibroblasts microinjected with LRB-TM-5b. Visualization of microinjeeted LRB-TM-Sb in fibro- 
blasts can be seen in A, (7, and E. Striations are clearly seen in the confluent cell shown in A. The corresponding  phase micrograph  is 
shown in B. D and F show the same fields as C and E, respectively, but with filters to reveal FITC-phalloidin staining of microfilaments. 
ments in this cell also (see arrows),  a pattern that is com- 
monly seen with TM antibodies. The dark interband region 
has been shown to be the site of ot-actinin on the filaments 
(Feramisco and Blose,  1980).  Fig.  8 D  is the same cell as 
in C but viewed with optics to reveal FITC-phalloidin stain- 
ing of F-actin. Some, but not all of  the ruffles show phalloidin 
staining and the striations are not visible. Fig. 8 E shows an- 
other LRB-TM-2 injected cell while panel F shows the same 
field with TM antibody staining in the FITC channel.  Note 
that the injected cell appears more brightly stained with the 
antibody than surrounding cells but does not show any mor- 
phological alteration. 
LRB-TM-3 microinjected cells are shown in Fig.  9.  Fig. 
9, A, C, and E  show TM-3 incorporated into all regions of 
The Journal of Cell Biology, Volume 118,  1992  852 Figure 11. LRB-TM-Sa labeling of micmfilaments in fibroblasts. A, C, and E show REF 52 cells microinjected  with LRB-TM-5a. The 
microfilaments are labeled throughout their length and no unlabeled micmfilaments were found when compared to the phalloidin stain. 
The corresponding FITC-phalloidin-st ained fields are shown in B, D, and E Some staining of  the nuclear region was noted with this isoform. 
This perinuclear  staining was also seen with the other isoforms before their pre-binding  to F-actin but remained  with TM-5a. 
the microfilament system. The arrowheads in Fig. 9 A point 
to  areas  of increased  fluorescence  which  correspond  to 
membrane ruffles in the phase image in Fig. 9 B. Fig. 9, D 
and F  show the FITC-phalloidin-labeled actin filaments in 
the injected and neighboring cells. No morphological altera- 
tions are apparent in the injected cells. The TM striations are 
not well developed, but still present.  In general, striations 
were well developed in well spread, confluent cells and rarely 
seen in active, motile cells. 
Fig. 10 shows the results of microinjecting TM-5b labeled 
Pittenger  and  Helfman Characterization  of  Fibroblast  Tropomyosins  853 Figure ]2. Microinjection of cells with two TM isoforms labeled with contrasting fluors show coincident stainlng. A shows FITC-TM-2, 
while B shows LRB-TM-5a in the same cell. C and E are examples of FITC-TM-3 in microinjected cells and D and F show LRB-TM-5b 
in the respective cells. In each example, both isoforrns are found throughout the cells, at the cell periphery and in long cellular extensions. 
with LRB. In Fig. 10 A, well-developed striations are present 
in this injected cell of a confluent monolayer (see phase im- 
age in Fig.  10 B). Other examples of LRB-TM-Sb microin- 
jeered cells are shown in Fig. 10, C and E while D and E show 
the  injected  cells  and  neighboring  cells  labeled  with 
FITC-phalloidin. In these examples, it can be seen that at 
the level of the light microscope, all actin filaments labeled 
with phalloidin are also labeled with this shorter TM isoform 
and the labeling of microfilaments is indistinguishable from 
that found with TM-2 or TM-3. 
LRB labeled TM-5a was also microinjected into REF 52 
cells and representative results are shown in Fig. 11. TM-5a 
was found to bind along microfilaments and striations could 
be weakly seen, but the level of incorporation into filaments 
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C, and E  show cells microinjected with LRB-TM-5a while 
Fig. 11, B, D, and F show the same cells and their neighbors 
labeled with FITC-phalloidin. As well as the filamentous ac- 
tin  labeling  seen with the other  isoforms,  some localization 
appeared present that  weakly labeled the nuclear region. 
This localization  was difficult  to focus  and did not depict 
known structures  and  may represent  non-specific  staining  as 
similar  nuclear region  staining  was also  seen with the  other 
isoforms  when  the labeled TMs  were  not prebound  to 
F-actin. 
The images of the fluorescently  labeled TMs  microin- 
jected  into  fibroblasts  always appeared as  if  each  isoform la- 
beled the  same population of  actin  filaments.  To investigate 
this  further,  mixtures of  two TM  isoforms labeled  with con- 
trasting  fluorochromes were  co-microinjected  into  cells.  Ex- 
amples  of the  results are  shown  in Fig. 12  at higher 
magnification than in previous figures.  Fig. 12 A  shows 
FITC-TM-2-1abeled  filaments  while Fig. 12 B  shows the 
same cell  with rhodamine  optics  to show the co-injected 
LRB-TM-5a.  FITC-TM-3-1abeled microfilaments  are  shown 
in  C and  E and  the  corresponding labeling  with LRB-TM-5b 
in  the  respective  cells  is  shown in  D  and  F.  The staining  ap- 
pears  coincident  in  both stress  fibers  and  fine  microfilaments 
at  the  cell  periphery for  the  pairs  of  short  and  long isoforms. 
These experiments were repeated  with the isoforms labeled 
with  the  opposite  fluorochromes and  with the  co-injection  of 
TM-2 and  TM-5b with  comparable results  (data  not  shown). 
Using microinjection,  there  is  a range of  volumes that  ac- 
tually  enters  the  cells.  However, the  results  were essentially 
the  same whether a  small  or  large  amount of  labeled-TM iso- 
form was injected.  An example of  this  is  shown in  Fig. 13, 
where in  a field  of  confluent  cells,  the  filamentous and stri- 
ated labeling  of  actin  filaments  with LRB-TM-5b  is  clearly 
seen in the cell to the lower right in B. Two cells to the left 
in  Fig.  13  B  have  a  much  higher  fluorescence intensity 
which, upon adjusting the exposure level, can be seen to be 
similarly filamentous (C). 
In summary, at the level of  fluorescence microscopy, it was 
found that  each isoform appeared to uniformly label the 
same actin filaments, without a preference for a particular 
subset of filaments or region of the cell. With few exceptions 
(see Fig. 8, Cand D) the TM fluorescence was always coinci- 
dent with phalloidin staining which is known to bind F-actin 
but not G-aetin. There was not a preference of the lower mo- 
lecular weight TMs (Sa or 5b) for the ruffling edge of the cell 
as has been reported using antibody staining  (Lin et al., 
1988). Each isoform appeared to give very similar labeling 
of actin filaments and each was seen to label filaments in a 
striated fashion in confluent cells. However, TM-5a consis- 
tently produced fainter images and slight nuclear staining. 
This nuclear staining could not be easily focused in the mi- 
croscope.  Similar staining was also noted with other iso- 
forms if the labeled isoforms were microinjected into cells 
without an F-actin binding step following the labeling reac- 
tion. The co-injection of labeled isoforms showed identical 
staining patterns in the cell and this co-localization extended 
to even the finest extensions of the cell periphery. Clearly, 
the shorter isoform TM-5b, does label actin filaments with 
a  similar  distribution  as  the  longer  isoforms  TM-2  and 
TM-3. These longer forms are also found in fine cellular ex- 
tensions where they are not part of a soluble pool that is ex- 
Figure 13.  Pattern of microfilament staining is not altered by the 
amount of  labeled isoform injected into the cell. A difference in the 
amount of LRB-5B injected into fibroblasts did not change the lo- 
calization of the isoform. A is a phase image of confluent REF 52 
cells. B and C show a short and long exposure respectively of the 
same field in which two cells are higldy fluorescent while a third 
cell has a decreased level of fluorescence due to difference in the 
amount  of injected  protein.  The  filamentous  staining  is  quite 
similar. 
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ton. For TM-5a, the results are similar to the other isoforms 
except for the association with the nuclear region which may 
be non-specific. 
Discussion 
Biochemical Characterization of  Bacterially 
Produced TMs 
While much is known about the structure and function of 
TMs from striated muscle, relatively  little  is known about 
the isoforms from non-muscle cells. This is in large part due 
to the difficulty  in isolating  the individual  isoforms from 
cells and tissues. By expressing the cDNA clones in bacteria, 
it is possible to obtain the individual  TMs. In this paper, we 
demonstrate the usefulness of this  approach  to study the 
fibroblast TMs. Four fibroblast isoforms, all products of the 
rat ot TM gene, were prepared in an E. coli expression sys- 
tem and subsequently used to study their biochemical and bi- 
ological properties.  These studies  demonstrate  that  these 
bacterially produced TMs have biochemical properties simi- 
lar to their  cellular counterparts. 
Amino acid sequencing  of each purified TM showed no 
blocked amino termini  and  the correct  sequence for the 
amino and carboxy termini  of each isoform.  It is of interest 
that the bacteria have removed the amino-terminal  methio- 
nine from TM-5a and TM-5b but not from TM-2 and TM-3. 
In vertebrate cells, this modification  of TMs has only been 
reported for the equine platelet TM (Cot~ et al., 1978) which 
is the homolog of the rat TM-4 protein (Yamawaki-Kataoka 
and Helfman, 1987). The function of this processing is un- 
known.  The amino termini of TM-5a and 5b from mam- 
malian sources have not yet been sequenced so it is unclear 
whether the methionine  is normally removed. In E. coli,  it 
has been shown that the penultimate  and,  sometimes, the 
third  amino  acid  residue  have  strong  bearing  on  NH2- 
terminal  excision by methionyl aminopeptidase  and this ac- 
tivity depends largely  on the size of the side chain  at the 
penultimate position (Hirel et ai., 1989). The TM-5a and 5b 
processing found here in E.  coli is consistent with these 
previous findings. 
Although  TMs  isolated  from  tissue  sources  have  an 
acetylated amino terminus (Cot6 et al.,  1978; Sanders and 
Smillie,  1978, 1985; Maket al., 1980), the function of this 
acetylation in vivo is not known. It has been suggested that 
it may neutralize the otherwise positive charge that would ex- 
ist on the amino terminus, and thereby aid the head-to-tall 
overlap of neighboring  TMs along the actin filament (Heald 
and Hitchcock-DeGregori,  1988).  The bacterially-derived 
fibroblast  isoforms lack this acetylation but bind to F-actin 
in vitro with properties comparable to TMs isolated from 
skeletal muscle. In contrast, studies of skeletal muscle r 
produced in bacteria showed that it bound poorly to actin 
(Hitchcock-DeGregori  and  Heald,  1987).  These  authors 
suggested  that  this was because the E.  coli product is not 
acetylated. We have also produced the skeletal muscle ot-TM 
in bacteria and observed that it does not bind as well as the 
fibroblast isoforms to actin filaments in vitro even when pre- 
bound to F-actin  and  repurified  (our unpublished results). 
However, it is likely that the differences in the actin-binding 
properties between the fibroblast and striated muscle iso- 
forms produced in E. coil are due to differences in the car- 
boxy termini of these proteins because except for the COOH 
terminus,  the fibroblast TM-2 is identical  to the skeletal 
muscle o~-TM. In addition,  although the high and low molec- 
ular  weight  fibroblast  isoforms reported here differ from 
each other at amino-terminal  and internal  regions,  they all 
contain the same carboxy terminal coding region. In con- 
trast, the skeletal muscle c~-TM  contains a different carboxy- 
terminus  (exon 9b in Fig. 1). Lin and co-workers (personal 
communication)  used bacterial expression to produce hu- 
man fibroblast TM-3 and TM-5a and chicken smooth muscle 
a-TM for biochemical studies.  Similar to our results,  these 
authors also found that the lack of acetylation did not inhibit 
F-actin binding.  Collectively,  the foregoing  results  suggest 
that the differences in F-actin binding between the fibroblast 
isoforms and skeletal muscle ot-TM lie in this carboxy termi- 
nal region. 
Previous studies of TMs isolated from cellular and tissue 
sources have demonstrated that  the low molecular weight 
TM from intestinal  epithelium bound strongly to F-actin 
whereas the low molecular weight TMs from brain (Broschat 
and Burgess,  1989) or a mixture of the low molecular weight 
TMs  from  fibroblasts  bound  poorly  (Matsumura  and 
Yamashiro-Matsumura,  1985). We have recently shown that 
the low molecular weight TM from intestinal  epithelium  is 
predominantly  TM-5b,  whereas  normal  rat  fibroblasts 
(REF-52 cells) contain predominantly TM-5a (Goodwin et 
al., 1991). These two isoforms differ only in the region from 
amino acids 153-177 due to the alternative  splicing of exons 
6a and 6b (see Fig.  1). There are 16 of 24 amino acid differ- 
ences between these two exons. We hypothesized that,  due 
to the amino acid differences  in this region, TM-5b would 
have a stronger affinity for actin filaments relative to TM-5a 
(Goodwin et al., 1991). This region of TM-5a is identical to 
amino acids 189-213 of striated muscle a  TM. In this seg- 
ment of the striated muscle isoform, the actin binding repeat 
described by McLachlan and Stewart (1976) is interrupted, 
presumably because of the requirement for troponin T bind- 
ing,  needed for the regulation  of muscle contraction.  The 
amino acids in this region of TM-5b however, maintain  the 
actin binding motif. It is worth noting that the low molecular 
weight isoforms from brain are comprised of TMBr-3 and 
TM-5a of the a-TM gene, and TM-4 from the TM-4 gene 
(Lees-Miller et al.,  1990).  These isoforms are highly con- 
served in the region of amino acids 153-177 (this region is 
encoded by exon 6b in TM-5a), and therefore could be ex- 
pected  to  bind  with  lower  affinity  to  actin  as  reported 
(Broschat  and Burgess,  1989) than isoforms containing  se- 
quences similar to those found in amino acids 153-177 of 
TM-5b  (encoded by exon  6a)  (see  Fig.  1).  The  results 
presented in this study showing that TM-5b is more efficient 
than TM-5a in displacing  TM-2 from F-actin supports this 
hypothesis (Fig.  4).  TM-5b is also capable of displacing 
TM-3 or skeletal muscle TMs prepared from rabbit muscle 
from F-actin with similar ability. We also extended the com- 
petition  experiments  to TM-3 and skeletal  muscle TM (a 
and ~ isoforms) because we suspected that TM-3 would be 
most strongly bound to F-actin as it contains exon 6a, as well 
as being a 284 a.a.  isoform capable of stronger head-to-tall 
overlap.  We were surprised to find that TM-5b could dis- 
place TM-3 (see Fig. 5 A) and that TM-3 and TM-2 showed 
approximately  the same binding  ability.  Th~  results sng- 
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within exon 2b of TMs 2 and 3 has a negative effect on their 
ability to interact with microfilaments. Experiments are in 
progress to distinguish these possibilities. 
Bacterially Produced TMs Bind to Actin 
Filaments In Vivo 
The work presented here shows that bacterially produced 
tropomyosin isoforms can be used to study the in vivo prop- 
erties of these proteins. After microinjection, fluorescently 
labeled  TM-2,  TM-3,  TM-5b  and  TM-5a  were  found 
throughout the  microfilament network.  However,  TM-5a 
gave a  relatively less intense fluorescence image than the 
other isoforms and also showed some nuclear region local- 
ization. The isoforms were all labeled at approximately the 
same dye-to-protein ratio, so the fainter microfilament local- 
ization is most likely due to a lower ability of TM-5a to in- 
corporate into actin filaments relative to the other isoforms. 
This is consistent with the in vitro studies showing that TM- 
5a was displaced from actin filaments by TM-5b (Fig. 4). 
The  nuclear  localization was  also  found with  the  other 
fluorescently  labeled TMs when they were not bound to actin 
and repurified prior to microinjection. However, for labeled 
TM-5a treated in a similar fashion this localization still per- 
sists. This nuclear localization was diffuse and therefore did 
not appear to represent known structures. Whether this is 
true localization of this isoform or represents non-specific 
binding of TM-5a will require additional experiments. 
Previous studies to analyze the distribution of TMs in 
fibroblasts by microinjection were limited to TMs isolated 
from smooth muscle and brain. Much of this previous work 
was accomplished before the number of TM isoforms or an 
understanding of the alternative splicing patterns for TM 
genes was known. Our experiments extend these studies and 
are the first to use the fibroblast isoforms for localization in 
fibroblasts. The fluorescence patterns obtained with the in- 
dividual microinjected fibroblast TMs are largely in agree- 
ment with previous studies using both antibodies (Lazarides, 
1975,  1976;  Warren et  al.,  1985;  Lin et al.,  1988)  and 
microinjection of fluorescentiy labeled smooth muscle and 
brain TMs 0Vehland and Weber, 1980; Dome et al., 1988), 
showing that TMs are associated with the actin-containing 
microfilaments of the cytoskeleton. 
Although distinct functions based on differential localiza- 
tion of various isoforms is an intriguing model, we have not 
seen evidence for this in the present study.  To date, differ- 
ences in TM isoform localization in fibroblasts have only 
been demonstrated in one study using antibodies that recog- 
nize either low or high molecular weight isoforms (Linet al., 
1988).  The low molecular weight forms were found in both 
ruffles and stress  fibers  while the high molecular weight 
forms were found only in stress fibers. In contrast, using 
microinjection of fluorescentiy labeled proteins, we did not 
detect differences in the localization of the isoforms in actin- 
containing structures. While localizations of injected tropo- 
myosins in cellular processes and cell bodies were noticed, 
these were not specific for any of the c~ gene isoforms used 
and this was more clearly shown in the double label experi- 
ments (Fig. 12). Whether this reflects the limitations of  using 
E.  coli produced proteins or that other fibroblast TM iso- 
forms will show different localizations is unknown. For ex- 
ample,  the distribution of rat fibroblast TM-I  and TM-4, 
which are the most abundant high and low molecular weight 
isoforms in REF-52 cells (Matsumura et al., 1983) has not 
yet been determined. Another concern is whether the micro- 
injection of relatively large amounts of purified labeled TM 
correctly mimic the localization of the endogenous isoforms. 
Towards this question, it should be noted that in a field of 
microinjected cells there is a range of volumes that actually 
enters the cells.  Although the total fluorescence intensity 
was seen to vary between injected cells, this did not result 
in a difference in isoform localization (see Fig. 13 and Re- 
suits).  Furthermore, labeled TMs were injected at a wide 
range of protein concentrations, and no differences in the lo- 
calization of the various isoforms was detected (data not 
shown). It is worth noting that at the level of the light micro- 
scope the co-injection of  labeled TMs appears to give coinci- 
dent staining, but the resolution does not allow the deter- 
mination of  whether each isoform is present on the same actin 
filament or on an adjacent filament. Moreover, along the illa- 
ments, there are two grooves in which the tropomyosin re- 
sides. If the TM isoforms are on the same filament, what is 
their arrangement? Is it random or is there a specific pattern 
or distribution of TM isoforms along an actin filament? This 
question may be answered at the electron microscope level 
by labeling the isoforms produced in E. coli with epitope tags 
and using epitope antibodies or labeling the TMs with col- 
loidal gold particles of differing diameters to locate the TM 
isoforms following microinjection. Finally, it is possible that 
TM isoforms are differentially  localized, but the mechanism 
also  involves the  localization of the  mRNA.  For  exam- 
ple, evidence for localization of mRNA has been shown for 
certain cytoskeletal proteins (Lawrence and Singer,  1986; 
Garner et al.,  1988) as well as homeotic mRNAs (Berlath 
et al., 1988; see also Rebagliati et al., 1985). If such a mech- 
anism does exist, microinjection of TM protein may not ex- 
hibit the proper subcellular distribution. 
Differences in the relative amounts of each of the TM iso- 
forms  could  also  provide  a  mechanism  for  regulating 
microfilament  assembly. The changes in the levels of various 
TM isoforms following transformation correlate with altera- 
tions in microfilament structure but no evidence providing a 
direct link between these events has been reported. Another 
possibility is that the various TM isoforms may be important 
for the binding of other cellular proteins to actin filaments. 
Accordingly, such proteins might interact with the microfila- 
ment system by associating with particular  TM  isoforms 
bound along the actin filaments. In this regard, we have seen 
evidence for the differential interaction of ~2~I-labeled TM- 
5a and TM-5b with proteins from several tissues (Pittenger, 
M., and D.  Helfman, unpublished results).  Using similar 
techniques, tropomodulin, a TM-binding protein has been 
identified and isolated from erythrocyte  membranes (Fowler, 
1987). Clearly, further studies are needed in order to eluci- 
date the significance of TM isoforms in cellular function. 
With the availability of  the different  isoforms, both biochemi- 
cal and cellular properties of these proteins can be addressed 
in the future. 
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